News Generation Bio Co.

Equities

GBIO

US37148K1007

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
2.9 ^USD	-3.65%		+3.57%	+75.76%

Apr. 12	Transcript : Generation Bio Co. - Special Call
Mar. 07	Needham Cuts Price Target on Generation Bio to $10 From $14, Maintains Buy Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting	Apr. 22	GL
Transcript : Generation Bio Co. - Special Call	Apr. 12
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference	Apr. 02	GL
Needham Cuts Price Target on Generation Bio to $10 From $14, Maintains Buy Rating	Mar. 07	MT
Generation Bio Co. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06	CI
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results	Mar. 06	GL
Generation Bio Co. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 06	CI
Transcript : Generation Bio Co. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 09:10 AM	Mar. 05
Generation Bio to Present at the 2024 TD Cowen Health Care Conference	Feb. 27	GL
Generation Bio to Present at the 2024 TD Cowen Health Care Conference	Feb. 27	AQ
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	GL
Generation Bio Co.(NasdaqGS:GBIO) dropped from NASDAQ Biotechnology Index	Dec. 15	CI
Generation Bio Insider Bought Shares Worth $124,778, According to a Recent SEC Filing	Dec. 05	MT
Wedbush Adjusts Generation Bio Price Target to $5 From $9, Maintains Outperform Rating	Nov. 29	MT
Generation Bio to Lay Off 40% of Staff in Bid to Extend Cash Runway Into H2 2027	Nov. 29	MT
Generation Bio Co. Announces Termination of Executives, Effective on January 28, 2024	Nov. 29	CI
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms	Nov. 29	GL
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms	Nov. 29	AQ
Wedbush Lowers Generation Bio's Price Target to $9 From $11, Maintains Outperform Rating	Nov. 10	MT
Generation Bio Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Generation Bio Co.

Equities

GBIO

US37148K1007

Summary

Filters